prof. dr. H.J. (Hiddo) Lambers Heerspink

Clinical Pharmacologist


  1. Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis

    de Jong, M. A., Petrykiv, S. I., Laverman, G. D., van Herwaarden, A. E., de Zeeuw, D., Bakker, S. J. L., Heerspink, H. J. L. & de Borst, M. H. 7-Jan-2019 In : Clinical Journal of the American Society of Nephrology. 14, 1, 8 p.

    Research output: Contribution to journalArticle

  2. Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial

    de Zeeuw, D., Renfurm, R. W., Bakris, G., Rossing, P., Perkovic, V., Hou, F. F., Nangaku, M., Sharma, K., Heerspink, H. J. L., Garcia-Hernandez, A. & Larsson, T. E. Dec-2018 In : Lancet Diabetes & Endocrinology. 6, 12, p. 925-933 9 p.

    Research output: Contribution to journalArticle

  3. Evaluation of Surrogate End Points for Progression to ESKD: Necessary and Challenging

    Inker, L. A. & Heerspink, H. L. Dec-2018 In : American Journal of Kidney Diseases. 72, 6, p. 771-773 3 p.

    Research output: Contribution to journalEditorial

  4. Baseline characteristics and enrichment results from the SONAR trial

    Heerspink, H. J. L., Andress, D. L., Bakris, G., Brennan, J. J., Correa-Rotter, R., Hou, F. F., Kitzman, D. W., Kohan, D., Makino, H., McMurray, J., Perkovic, V., Tobe, S., Wigderson, M., Yi, T., Parving, H-H. & de Zeeuw, D. Aug-2018 In : Diabetes obesity & metabolism. 20, 8, p. 1829-1835 7 p.

    Research output: Contribution to journalArticle

View all (236) »

View graph of relations

ID: 208085